Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01988883
EARLY_PHASE1

Modafinil and Cognitive Function in POTS

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

A common complaint among patients with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This problem is poorly understood. The purpose of this study is to better understand the cognitive dysfunction associated POTS, and to determine optimal treatment strategies for this condition. In this study, the investigators will test the hypothesis that acute administration of the psychostimulant drug modafinil can improve seated measures of cognitive function in patients with POTS.

Official title: Modafinil and Cognitive Function in Postural Tachycardia Syndrome

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2014-10

Completion Date

2026-12

Last Updated

2026-01-15

Healthy Volunteers

No

Interventions

DRUG

Placebo

Locking gelatin capsules filled with microcrystalline cellulose

DRUG

Modafinil

Modafinil is a wakefulness-promoting or psychostimulant drug. It will be administered as a single 200 mg oral tablet.

DRUG

Propranolol

Propranolol is a non-selective beta adrenergic antagonist.It will be administered as a single 20 mg oral tablet.

Locations (1)

Vanderbilt University

Nashville, Tennessee, United States